The FDA issued a formal proposal on April 30, 2026 that, if finalized, would further restrict outsourcing-facility compounding of semaglutide, tirzepatide, and liraglutide from bulk substances under section 503B
Hines, Lipedema of the Legs: A Syndrome Characterized by Fat Legs and Edema
Many private GP clinics and aesthetic wellness clinics across the Klang Valley, Penang, and Johor Bahru stock Ozempic
Treatment discontinuation (34%) was the most common censoring reason (Supplementary Table 20)
Like any medication, Zepbound comes with important safety considerations, including possible side effects, serious risks, and certain conditions where it may not be safe to use
Whether you require a specific dosage, an alternative form of medication, or are managing allergies to common ingredients, our compounding services offer effective solutions